©2018 by APMI


Following the APMI conceptual framework, mono-center pilot APMI cohorts (belonging to the APMI-CP) – spanning from early asymptomatic preclinical populations to prodromal to dementia late stage populations – have been established at the central clinical recruitment site, the Institute of Memory and Alzheimer's Disease (Institut de la mémoire et de la maladie d'Alzheimer, IM2A, Pitié-Salpêtrière University Hospital in Paris.

These pilot APMI cohorts:
- include both cognitively intact older individuals at risk for Alzheimer’s Disease and patients with a full range of neurodegenerative diseases
- Provide an assortment of unique heterogeneous and multidimensional data

Currently established pilot APMI cohorts: